David Hollander

Business address
C/O Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, NC, 27703
Top holdings (ownership)
AERI
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
David Hollander has filed 15 SEC EDGAR filings since 13 Nov 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 02 Apr 2025 01 Apr 2025 001-36672
4 Open Document Open Filing 4 06 Feb 2025 04 Feb 2025 001-36297
4 Open Document Open Filing FORM 4 19 Nov 2024 18 Nov 2024 001-36297
4 Open Document Open Filing FORM 4 03 Jul 2024 01 Jul 2024 001-36672
3 Open Document Open Filing FORM 3 29 Feb 2024 27 Feb 2024 001-36297
4 Open Document Open Filing FORM 4 03 Oct 2023 29 Sep 2023 001-36672
4 Open Document Open Filing FORM 4 07 Mar 2023 03 Mar 2023 001-36672
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2022 04 Feb 2022 001-36152
4 Open Document Open Filing OWNERSHIP DOCUMENT 03 Feb 2022 01 Feb 2022 001-36672
3 Open Document Open Filing OWNERSHIP DOCUMENT 23 Dec 2021 13 Dec 2021 001-36672
4 Open Document Open Filing FORM 4 SUBMISSION 15 Nov 2021 11 Nov 2021 001-36152
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2021 04 Feb 2021 001-36152
4 Open Document Open Filing FORM 4 SUBMISSION 12 Nov 2020 11 Nov 2020 001-36152
4 Open Document Open Filing FORM 4 SUBMISSION 13 Nov 2019 11 Nov 2019 001-36152
3 Open Document Open Filing FORM 3 SUBMISSION 13 Nov 2019 11 Nov 2019 001-36152